US Pharma Company Artelo Announces Launch of Solana Reserve Asset Strategy
By: theblockbeats.news|2025/08/04 13:02:14
BlockBeats News, August 4th, Pharmaceutical company Artelo Biosciences (Nasdaq: ARTL) announced the completion of a $9.475 million off-market private placement, which will be used to launch a Solana (SOL)-centered digital asset reserve strategy, making it the first publicly traded pharmaceutical company to include SOL as a reserve asset.
This private placement includes the issuance of common stock (or pre-funded warrants) at a price of $10.45 per share, as well as two tranches of warrants with exercise prices of $10.20 and $50, respectively, with a three-year term. The transaction is expected to be completed on August 5, 2025.
The Ether Machine has announced an increase in holdings of 10,605 ETH, bringing the total holdings to 345,362 ETH.
US Stock DFDV Announces Increase in Holding of 110,000 SOL, Bringing Total Holdings to 1,293,000 SOL
You may also like
Share
Gainers
Latest Crypto News
01:45
Telegram Founder: Decentralized Secure Computation Network Cocoon is Now Live
01:45
A Whale Doubles Down on Short Position of Over 6300 ETH, Realizing a Floating Profit of $1 Million in Just 1 Hour
01:45
Kalshi Faces Class Action Lawsuit, Accused of Conducting Sports Betting Operations Without a License
01:45
Prediction: The first spot LINK ETF will be launched this week
01:45
Analysis: The "1011" clearing event and the increasingly challenging macro environment have been the main drivers of the recent downturn.
Read more
Community
Customer Support:@weikecs
Business Cooperation:@weikecs
Quant Trading & MM:bd@weex.com
VIP Services:support@weex.com